Breaking News Instant updates and real-time market news.

CASA

Casa Systems

$15.02

-0.03 (-0.20%)

, SCHW

Charles Schwab

$44.42

0.25 (0.57%)

10:16
11/30/18
11/30
10:16
11/30/18
10:16

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Casa Systems (CASA) initiated with a Buy at Needham. 2. Charles Schwab (SCHW) and E-Trade (ETFC) were initiated with a Buy at Goldman Sachs. 3. Forty Seven (FTSV) initiated with a Buy at H.C. Wainwright. 4. Akoustis (AKTS) initiated with a Buy at Lake Street. 5. Everi Holdings (EVRI) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

CASA

Casa Systems

$15.02

-0.03 (-0.20%)

SCHW

Charles Schwab

$44.42

0.25 (0.57%)

ETFC

E-Trade

$51.88

0.42 (0.82%)

FTSV

Forty Seven

$18.88

1.27 (7.21%)

AKTS

Akoustis

$4.78

-0.13 (-2.65%)

EVRI

Everi Holdings

$6.82

0.3 (4.60%)

  • 01

    Dec

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 11

    Dec

  • 12

    Dec

CASA Casa Systems
$15.02

-0.03 (-0.20%)

10/22/18
STFL
10/22/18
INITIATION
Target $18
STFL
Buy
Casa Systems resumed with a Buy at Stifel
Stifel analyst John Marchetti resumed Casa Systems with a Buy rating and a price target of $18, saying the company is "well positioned to benefit from ongoing cable operator infrastructure and capacity upgrades in the near term". The analyst adds that Casa System is also "positioning itself to capitalize on technology shifts toward distributed access architectures and mobile network convergence over the long-term". Marchetti sees the stock trading at an "attractive valuation" as his price target represents a 4.1-times enterprise value to expected sales multiple.
08/24/18
LOOP
08/24/18
UPGRADE
Target $18
LOOP
Buy
Casa Systems upgraded to Buy from Hold at Loop Capital
Loop Capital analyst James Kisner upgraded Casa Systems to Buy and raised his price target for the shares to $18 from $12. Recent softness in the business is chiefly a function of customer concentration, Kisner tells investors in a research note titled "The House of the Rising Sun." He believes the "sun will rise again" for Casa as cable operators continue to invest in their networks to accommodate higher speeds and data traffic growth. Consensus estimates for the second half of 2018 are achievable even if Casa's two biggest customers are down 30% year-over-year, Kisner contends.
08/15/18
LOOP
08/15/18
NO CHANGE
Target $12
LOOP
Hold
Casa Systems price target lowered to $12 from $16 at Loop Capital
Loop Capital analyst James Kisner lowered his price target on Casa Systems to $12 and kept his Hold rating after its Q2 earnings miss and lowered expectations for FY18. Kisner notes the earnings miss was driven by a push-out of orders and revenue recognition, and lowered guidance was a victim to a "more deliberate pace of infrastructure deployments by cable operators". The analyst states that he is keeping a positive view of the cable access market in the long term, but adds that the last quarter highlighted Casa Systems' risks around customer concentration and "lumpy order patterns".
11/29/18
NEED
11/29/18
INITIATION
Target $19
NEED
Buy
Casa Systems initiated with a Buy at Needham
Needham analyst Richard Valera started Casa Systems with a Buy rating and $19 price target. The analyst believes the company is positioned for sustained double-digit sales growth with continued 30%-plus operating margins.
SCHW Charles Schwab
$44.42

0.25 (0.57%)

11/30/18
GSCO
11/30/18
INITIATION
GSCO
Buy
Charles Schwab initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Will Nance initiated coverage of the Online Brokers with an Attractive coverage view, stating that for the group on the whole he believes cyclical factors will drive fundamentals and valuation in the near term despite organic growth and pricing concerns. He set a Buy rating on Charles Schwab (SCHW), stating that it along with E-Trade (ETFC) screens as the most defensive. He notes that his 2019 and 2020 estimates for Schwab are 2% and 8%, respectively, above Factset consensus.
11/26/18
SBSH
11/26/18
UPGRADE
Target $45
SBSH
Neutral
Charles Schwab upgraded to Neutral from Sell at Citi
Citi analyst William Katz upgraded Charles Schwab to Neutral while lowering his price target for the shares to $45 from $46.
11/30/18
GSCO
11/30/18
INITIATION
Target $64
GSCO
Buy
E-Trade initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Will Nance initiated coverage of the Online Brokers with an Attractive coverage view, stating that for the group on the whole he believes cyclical factors will drive fundamentals and valuation in the near term despite organic growth and pricing concerns. He set a Buy rating on E-Trade (ETFC), stating that it along with Charles Schwab (SCHW) screens as the most defensive. He notes that his 2019 and 2020 estimates for E-Trade are 5% and 9%, respectively, above Factset consensus. Nance set a $64 price target on E-Trade shares and a $55 price target on Charles Schwab.
11/26/18
SBSH
11/26/18
UPGRADE
Target $45
SBSH
Neutral
Citi upgrades Schwab to Neutral on more balanced risk/reward
Citi analyst William Katz upgraded Charles Schwab to Neutral from Sell while lowering his price target for the shares to $45 from $46. After examining whether retail brokers can prove defensive against higher volatility and/or a more decisive market downturn, the analyst sees a more balanced risk/reward at current share levels.
ETFC E-Trade
$51.88

0.42 (0.82%)

10/30/18
10/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. LabCorp (LH) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg saying the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. 2. E-Trade (ETFC) downgraded to Outperform from Strong Buy at Raymond James with analyst Patrick O'Shaughnessy saying the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan. 3. Southwest (LUV) downgraded to Underweight from Neutral at JPMorgan while United Continental (UAL) and Spirit Airlines (SAVE) downgraded to Neutral from Overweight. 4. Flex (FLEX) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound," as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. 5. Elevate Credit (ELVT) downgraded to Market Perform from Outperform at JMP Securities and William Blair. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/18
WOLF
11/02/18
UPGRADE
WOLF
Outperform
E-Trade upgraded to Outperform from Peer Perform at Wolfe Research
FTSV Forty Seven
$18.88

1.27 (7.21%)

07/23/18
FBCO
07/23/18
INITIATION
Target $24
FBCO
Outperform
Forty Seven initiated with an Outperform at Credit Suisse
Credit Suisse analyst Martin Auster started Forty Seven with an Outperform rating and $24 price target as he believes the stock offers a promising opportunity for investors to participate in the long-term potential of this class, with promising efficacy in NHL offering a valuation base, and substantial upside potential as its 5F9 efficacy data matures in other monotherapy and combination settings.
07/23/18
MSCO
07/23/18
INITIATION
Target $25
MSCO
Overweight
Forty Seven initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison initiated Forty Seven with an Overweight rating and $25 price target, stating that the company has a significant lead in developing anti-CD47 antibodies, which he believes offer broad applicability in cancer. Forty Seven has multiple mature clinical datasets, potentially placing it "years ahead" of competitors, Harrison tells investors.
10/09/18
FBCO
10/09/18
NO CHANGE
FBCO
Outperform
Forty Seven selloff on Celgene trial ending seems premature, says Credit Suisse
After Celgene (CELG) disclosed the termination of its trial for CC-90002, an IgG4 construct that targets CD47, in acute myeloid leukemia and myelodysplastic syndrome patients, Credit Suisse analyst Martin Auster said the associated selloff in shares of Forty Seven (FTSV) seems premature to him. He does not believe the discontinuation in AML/MDS has a negative read-through to Forty Seven's 5F9 profile to date or its development in other indications, Auster tells investors. The analyst, who keeps an Outperform rating on Forty Seven shares, still sees promising efficacy in NHL providing a strong valuation base with substantial upside potential offered as 5F9 efficacy data matures.
11/30/18
HCWC
11/30/18
INITIATION
Target $21
HCWC
Buy
Forty Seven initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Forty Seven with a Buy rating and $21 price target. The company's lead product, 5F9, is an anti-CD47 antibody that triggers macrophages to eat cancer cells by blocking the CD47-SIRPalpha pathway, which is frequently exploited by cancer cells for immune evasion, Ramakanth tells investors in a research note. He believes data suggest that 5F9 is synergistic with existing immunotherapies by making the tumor microenvironment less tumorigenic. If successful, 5F9 could become an important next-generation CPI to enter the cancer immunotherapy market, which is expected to grow to $43B by 2022, says the analyst.
AKTS Akoustis
$4.78

-0.13 (-2.65%)

10/10/18
PIPR
10/10/18
INITIATION
Target $10
PIPR
Overweight
Akoustis initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Harsh Kumar started Akoustis Technologies with an Overweight rating and $10 price target. The analyst believes the company is well positioned to participate in the upcoming 5G cycle with its BAW filter portfolio. Akoustis's single crystal BAW filters offer several technological benefits over the current market offerings, Kumar tells investors in a research note.
11/01/18
LOOP
11/01/18
NO CHANGE
LOOP
Akoustis price target lowered to $11 from $15 at Loop Capital
Loop Capital analyst Cody Acree reiterated a Buy rating on Akoustis Technologies but lowered his price target on shares to $11 from $15. Acree noted that the company's "pullback since its recent financing provides it with the resources to accelerate its product development and capacity expansion efforts, and help its customers become more confident in its ability to reliably manufacture in high volumes." However, despite the reiterated Buy rating, the analyst lowered his price target due to multiple contractions across most of the semi group.
11/30/18
LSCM
11/30/18
INITIATION
Target $10
LSCM
Buy
Akoustis initiated with a Buy at Lake Street
Lake Street analyst Jaeson Schmidt started Akoustis Technologies with a Buy rating and $10 price target. The company's "differentiated" products can help it gain share in the $5.4B bulk acoustic wave radio frequency filter market, Schmidt tells investors in a research note. He says Akoustis' expanding engagement pipeline will start to flow to profits in a "meaningful way" in the coming years.
09/24/18
LOOP
09/24/18
NO CHANGE
Target $15
LOOP
Buy
Akoustis on track to meet its targets, says Loop Capital
Loop Capital analyst Cody Acree kept his Buy rating and $15 price target on Akoustis after meeting with its management, saying the discussions added to his confidence of the company's ability to meet its WiFi, Radar, Infrastructure and Citizen Band Radio market targets. The analyst estimates that given its current headcount and a newly purchased fab in Canandaigua, New York, the company has the capacity to generate up to $200M in annual revenue.
EVRI Everi Holdings
$6.82

0.3 (4.60%)

11/30/18
RAJA
11/30/18
INITIATION
Target $11
RAJA
Strong Buy
Everi Holdings initiated with a Strong Buy at Raymond James
Raymond James initiated Everi Holdings with a Strong Buy and $11 price target.
11/16/18
JEFF
11/16/18
NO CHANGE
JEFF
Jefferies sees long-term investment opportunities in Gaming
The "profound weakness" in Gaming stocks has created dislocation which presents long-term investment opportunities, Jefferies analyst David Katz tells investors in a research note titled "'Buy On Weakness' Is Not Enough." The analyst says his "broad view" of asset value, leadership execution and capital structure risk lead to him focus on his top picks, Eldorado Resorts (ERI) and International Game Technology (IGT). He also has Buy ratings on Boyd Gaming (BYD), PlayAGS (AGS) and Everi Holdings (EVRI).
10/11/18
JEFF
10/11/18
NO CHANGE
JEFF
International Game, Everi pullbacks bring buying opportunity, says Jefferies
After attending the Global Gaming Expo, Jefferies analyst David Katz believes "broadly stronger" product offerings should be positive for Gaming stocks. The recent weakness in shares of International Game Technology (IGT) and Everi Holdings (EVRI), who both have "strong prospects," present buying opportunities, Katz tells investors in research note. He also believes PlayAGS' (AGS) relative outperformance is justified as its "growth opportunities warrant the premium multiple." Further, the analyst thinks Scientific Games (SGMS) has been overly pressured by a series of negative catalysts, "all of which should stabilize in time." The company's products "are too good for the shares' decline not to correct," Katz contends.
09/13/18
STFL
09/13/18
INITIATION
Target $13
STFL
Buy
Everi Holdings resumed with a Buy at Stifel
Stifel analyst Brad Boyer resumed coverage of Everi Holdings with a Buy rating and $13 price target. The company's current segment-level valuation "reflects a significant discount" when compared to prevailing public market multiples within the Gaming Equipment and Payments sectors, Boyer tells investors in a research note. He sees several potential catalysts that could narrow the valuation gap, including Everi's analyst day and the upcoming Global Gaming Expo. The analyst views the stock as a "one of the most compelling return opportunities for value investors of all varieties."

TODAY'S FREE FLY STORIES

EGIEY

Engie Brasil

$0.00

(0.00%)

05:03
11/14/19
11/14
05:03
11/14/19
05:03
Initiation
Engie Brasil initiated  »

Engie Brasil initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQUEY

Equatorial Energia

$0.00

(0.00%)

05:02
11/14/19
11/14
05:02
11/14/19
05:02
Initiation
Equatorial Energia initiated  »

Equatorial Energia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIG

Cemig

$3.02

-0.05 (-1.63%)

05:00
11/14/19
11/14
05:00
11/14/19
05:00
Initiation
Cemig initiated  »

Cemig initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

AGCO

Agco

04:56
11/14/19
11/14
04:56
11/14/19
04:56
Upgrade
Agco rating change  »

Agco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 13

    Dec

SERV

ServiceMaster

$34.11

-0.13 (-0.38%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
ServiceMaster management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

BTE

Baytex Energy

$1.24

-0.02 (-1.59%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Baytex Energy management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NOVA

Sunnova Energy

$9.85

-0.54 (-5.20%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Sunnova Energy management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 09

    Dec

04:55
11/14/19
11/14
04:55
11/14/19
04:55
General news
Breaking General news story  »

Federal Reserve Board of…

04:55
11/14/19
11/14
04:55
11/14/19
04:55
General news
Breaking General news story  »

Federal Reserve Board of…

04:55
11/14/19
11/14
04:55
11/14/19
04:55
General news
Breaking General news story  »

St. Louis Federal Reserve…

04:55
11/14/19
11/14
04:55
11/14/19
04:55
General news
Breaking General news story  »

Dallas Federal Reserve…

DNKN

Dunkin' Brands

$76.44

0.89 (1.18%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Dunkin' Brands management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BA

Boeing

$362.42

-0.47 (-0.13%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Cowen aerospace & defense analysts to hold analyst/industry conference call »

Aerospace & Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SYX

Systemax

$21.75

-0.345 (-1.56%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Systemax management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

VRRM

Verra Mobility

$14.70

0.045 (0.31%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Verra Mobility management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

BWEN

Broadwind Energy

$1.48

-0.05 (-3.27%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Broadwind Energy management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

EEFT

Euronet

$150.10

0.14 (0.09%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Euronet management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MDLZ

Mondelez

$52.70

0.62 (1.19%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Mondelez management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CNCE

Concert Pharmaceuticals

$6.91

-0.48 (-6.50%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Concert Pharmaceuticals to host conference call »

Management, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AB

AllianceBernstein

$29.77

0.22 (0.74%)

, BAC

Bank of America

$32.78

-0.32 (-0.97%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Nareit to hold a conference »

REITworld: 2019 Annual…

AB

AllianceBernstein

$29.77

0.22 (0.74%)

BAC

Bank of America

$32.78

-0.32 (-0.97%)

BBVA

Banco Bilbao

$5.23

-0.175 (-3.24%)

BRX

Brixmor

$21.85

0.34 (1.58%)

BXP

Boston Properties

$136.68

1.06 (0.78%)

C

Citi

$73.91

-1.17 (-1.56%)

CLDT

Chatham Lodging

$17.59

-0.225 (-1.26%)

COF

Capital One

$96.33

-0.89 (-0.92%)

CS

Credit Suisse

$12.84

-0.195 (-1.50%)

DRH

DiamondRock

$10.07

-0.1 (-0.98%)

EVER

EverQuote

$29.04

-0.06 (-0.21%)

DOC

Physicians Realty Trust

$18.33

0.11 (0.60%)

JEF

Jefferies Financial Group

$19.03

-0.23 (-1.19%)

JMP

JMP Group

$3.20

-0.04 (-1.23%)

KIM

Kimco Realty

$21.06

0.33 (1.59%)

LAMR

Lamar Advertising

$81.65

-0.37 (-0.45%)

LMRK

Landmark Infrastructure

$15.50

-0.11 (-0.70%)

MS

Morgan Stanley

$48.39

-0.62 (-1.27%)

PEB

Pebblebrook Hotel

$24.90

-0.13 (-0.52%)

O

Realty Income

$76.84

1.11 (1.47%)

RJF

Raymond James

$88.35

-1.29 (-1.44%)

REG

Regency Centers

$64.68

-0.13 (-0.20%)

RLJ

RLJ Lodging Trust

$16.44

-0.19 (-1.14%)

SKT

Tanger Factory

$15.97

0.08 (0.50%)

STOR

Store Capital

$39.84

0.845 (2.17%)

SF

Stifel Financial

$59.70

-1.83 (-2.97%)

SUI

Sun Communities

$157.14

2.355 (1.52%)

UDR

UDR, Inc.

$47.72

0.69 (1.47%)

UBS

UBS

$12.16

-0.17 (-1.38%)

WFC

Wells Fargo

$53.27

-0.96 (-1.77%)

WRE

Washington REIT

$30.32

-0.1 (-0.33%)

WY

Weyerhaeuser

$28.98

-0.16 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 14

    Jan

  • 14

    Jan

  • 15

    Jan

  • 31

    Jan

  • 11

    Feb

PTLA

Portola Pharmaceuticals

$27.36

-0.35 (-1.26%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Portola Pharmaceuticals to hold analyst and investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 07

    Dec

PRU

Prudential

$92.81

-0.52 (-0.56%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Prudential management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ATGE

Adtalem Global Education

$32.42

-0.16 (-0.49%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Adtalem Global Education management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

AMZN

Amazon.com

$1,753.84

-24.49 (-1.38%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55
Conference/Events
Amazon.com management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

04:55
11/14/19
11/14
04:55
11/14/19
04:55
General news
Breaking General news story  »

Federal Reserve Board of…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.